Works matching IS 10781552 AND DT 2021 AND VI 27 AND IP 6

Results: 34

Comment on biotin-induced thyroid stimulating hormone aberrations in the setting of immunotherapy.

Published in:

2021

By:

Ghazal, Khaldoun;
Piketty, Marie-Liesse

Publication type:

Letter

Updates in the management of relapsed/refractory multiple myeloma.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1477, doi. 10.1177/10781552211028906

By:

Hanna, Kirollos S;
Larson, Samantha;
Nguyen, Jenny;
Tu, Sarah;
Boudreau, Jenna;
Rose, Sarah

Publication type:

Article

The nivolumab/cabozantinib combination and the future of doublets in advanced renal cell cancer treatment.

Published in:

2021

By:

Lilly, Eddy;
Sarkis, Julien

Publication type:

Letter

Reduced emergency room visits and improved medication adherence of an integrated oncology pharmaceutical care practice in China.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1503, doi. 10.1177/10781552211027218

By:

Qi, Huijie;
Zhu, Lili;
Chen, Lu;
Zhang, Wenxin;
Wang, Tianxiao;
Chen, Haifei;
Wu, Qian;
Zhan, Qiong;
Le, Tianji;
Zhang, Liudi;
Zhong, Mingkang;
Shi, Xiaojin;
Li, Qunyi

Publication type:

Article

Novel targets for refractory kidney cancer: Where are we heading?

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1559, doi. 10.1177/10781552211027216

By:

Sarkis, Julien;
Sarkis, Pierre;
Alkassis, Marwan;
Assaf, Joy;
Ghazi, Rabih

Publication type:

Article

The growing importance of biomonitoring studies in professionals occupationally exposed to antineoplastic drugs: Conceptions, guidelines and critical questions.

Published in:

2021

By:

Malinverni, Andrea C M;
Castro-Champion, Glaucia de;
Souza, Daniel V de;
Silva, Regina C B da;
Ribeiro, Daniel A

Publication type:

Letter to the Editor

Difficulties in biomonitoration of occupational exposure to antineoplastic drugs.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1557, doi. 10.1177/10781552211026368

By:

Ness, Sandro Luis Ribeiro;
Arbo, Marcelo Dutra;
Ferreira, Charles Francisco

Publication type:

Article

Can biosimilar products be interchangeable? Pharmaceutical perspective in the implementation of biosimilars in oncology.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1491, doi. 10.1177/10781552211016099

By:

Soares, José Cleberson Santos;
Cavalcanti, Iago Dillion Lima;
Vasconcelos, Juliana Lúcia de Albuquerque

Publication type:

Article

Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer?

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1461, doi. 10.1177/10781552211015762

By:

Ayhan, Murat;
Laçin, Şahin;
Özyükseler, Deniz T;
Sürmeli, Heves;
Doğan, Akif;
Turan, Merve;
odabas, Hatice;
Turan, Nedim;
Yıldırım, Mahmut Emre

Publication type:

Article

Treatment outcomes among human epidermal growth factor receptor 2 positive breast cancer patients: A systematic review.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1468, doi. 10.1177/10781552211005530

By:

Degu, Amsalu;
Yussuf, Asha

Publication type:

Article

Gemcitabine-induced dilated-cardiomyopathy in patient with platinum-refractory ovarian-cancer: A case report and literature review.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1542, doi. 10.1177/1078155220982044

By:

Raimondi, Lucrezia;
Raimondi, Filippo Maria;
Rossi, Luigi;
Lazzeroni, Rachele;
Pietranera, Marta;
Di Benedetto, Laura;
Gozzi, Elisa;
Spinelli, Gian Paolo

Publication type:

Article

Delayed immune thrombocytopenia after discontinuation of nivolumab therapy: A case report and literature review.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1548, doi. 10.1177/1078155220981155

By:

Fu, Shengya;
Wang, Ting;
Xu, Feng

Publication type:

Article

Acute cytokine release syndrome after a first dose of pembrolizumab as second-line treatment for metastatic, programmed death-ligand 1-positive, non-small-cell lung cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1528, doi. 10.1177/1078155220980813

By:

Normand, Clément V;
Zender, Hervé O;
Staehli, Dominique M;
Chouiter-Djebaili, Amina Faiza;
John, Gregor

Publication type:

Article

Recurrent and reversible bilateral palmar blue discoloration following administration of liposomal daunorubicin-cytarabine (Vyxeos®) for acute myeloid leukemia with myelodysplasia-related changes.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1539, doi. 10.1177/1078155220978452

By:

Triesel, Katherine;
Chiang, Timothy;
Seabury, Robert;
Miller, Christopher

Publication type:

Article

Nivolumab for the salvage treatment of desperate germ cell tumor: A case report.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1516, doi. 10.1177/1078155220977638

By:

Aksun, MS;
Ucgul, E;
Sahin, TK;
Guven, DC;
Aksoy, S

Publication type:

Article

Late-onset double-seronegative myasthenia gravis syndrome and myasthenic crisis due to nivolumab use for Hodgkin's lymphoma.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1534, doi. 10.1177/1078155220976797

By:

Dang, Thai;
Macwan, Samir;
Dasanu, Constantin A

Publication type:

Article

Delayed presentation of doxorubicin extravasation into pleural space: Case report and review of literature.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1520, doi. 10.1177/1078155220975848

By:

Kazakova, Vera;
Vanegas, Yenny A Moreno;
Torres, Tyion A;
Kozyreva, Olga

Publication type:

Article

Drug-related problems in head and neck cancer patients identified by repeated medication reviews on consecutive therapy cycles.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1439, doi. 10.1177/1078155220962178

By:

Vucur, Corinna;
Wirtz, Daniel A;
Weinhold, Leonie;
Zipfel, Matthias;
Schmid, Matthias;
Schmidt-Wolf, Ingo GH;
Jaehde, Ulrich

Publication type:

Article

Enhancing patients' understanding of and adherence to oral anticancer medication: Results of a longitudinal pilot intervention.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1409, doi. 10.1177/1078155220960800

By:

Lin, Mingqian;
Hackenyos, Douglas;
Savidge, Nicole;
Weidner, Ruth Ann;
Murphy-Banks, Rachel;
Fleckner, Tara;
Parsons, Susan K;
Rodday, Angie Mae

Publication type:

Article

Leveraging advanced preparation of oncology medications: Decreasing turnaround-times in an outpatient infusion center.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1454, doi. 10.1177/1078155220960222

By:

Blackmer, James;
Amoline, Kevin;
Amancher, Jacqueline;
Vogan, Eric;
Zimmer, Heather;
Borton, Meave;
Earl, Marc;
Boyd, Anthony

Publication type:

Article

Does nutritional status affect treatment tolarability, response and survival in metastatic colorectal cancer patients? Results of a prospective multicenter study.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1357, doi. 10.1177/1078155220959427

By:

Karabulut, Senem;
Dogan, Izzet;
Usul Afsar, Cigdem;
Karabulut, Mehmet;
Karaman, Sule;
Ferhatoglu, Ferhat;
Tastekin, Didem

Publication type:

Article

Initial tacrolimus weight-based dosing strategy in allogeneic hematopoietic stem-cell transplantation.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1447, doi. 10.1177/1078155220959416

By:

Soskind, Rose;
Xiang, Elaine;
Lewis, Tyler;
Al-Homsi, A. Samer;
Papadopoulos, John;
Cirrone, Frank

Publication type:

Article

Outcomes with enoxaparin dose reductions during thrombocytopenia in patients with hematopoietic stem cell transplantation (HSCT).

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1364, doi. 10.1177/1078155220957747

By:

Lam, Jenna;
Tavares, Erica;
Luk, Samantha O

Publication type:

Article

Real-world intensive safety monitoring of biosimilars rituximab and trastuzumab in a Portuguese oncology hospital.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1432, doi. 10.1177/1078155220957079

By:

Mendes, Diogo;
Abrantes, Joana;
Rigueiro, Graça;
Pais, Ana Filipa;
Penedones, Ana;
Alves, Carlos;
Batel-Marques, Francisco

Publication type:

Article

Cyto-SAT: A self-assessment tool for the safe handling of cytotoxic drugs adapted for use in low- and middle-income countries.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1422, doi. 10.1177/1078155220956687

By:

von Grünigen, Sandrine;
Geissbühler, Antoine;
Bonnabry, Pascal

Publication type:

Article

Awareness is the first step: What Ghanaian community pharmacists know about cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1333, doi. 10.1177/1078155220955211

By:

Mensah, Kofi B.;
Mensah, Adwoa Bemah Boamah;
Bangalee, Varsha;
Oosthuizen, Frasia

Publication type:

Article

Anti-drug antibodies anti-trastuzumab in the treatment of breast cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1354, doi. 10.1177/1078155220953873

By:

Padrón, Ivette Mourani;
García, Jonathan González;
Díaz, Ruth Ramos;
Lenza, Isaac Ceballos;
Nicolás, Fernando Gutiérrez

Publication type:

Article

Development of a simple compatibility inspection method using pressure in a BD PhaSeal™ system and hazardous drug vials.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1321, doi. 10.1177/1078155220952518

By:

Ishimaru, Hiromasa;
Tsuda, Yasumasa;
Kage, Hidenori;
Kawano, Tomoaki;
Takayama, Shinji;
Morimoto, Yoshihito;
Goto, Kazumi;
Watanabe, Kazuhiro

Publication type:

Article

Involvement of C677T MTHFR variant but not A1298C in methotrexate-induced toxicity in acute lymphoblastic leukemia.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1382, doi. 10.1177/1078155220951898

By:

Frikha, Rim;
Jemaa, Maha Ben;
Frikha, Fakher;
Turki, Ines;
Elloumi, Moez;
Keskes, Leila;
Kamoun, Hassen;
Rebai, Tarek

Publication type:

Article

Evaluation of the efficacy of a self-cleaning automated compounding system for the decontamination of cytotoxic drugs.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1343, doi. 10.1177/1078155220951866

By:

Telleria, Naiara;
García, Nerea;
Grisaleña, Jaione;
Algaba, Naiara;
Bergareche, Eider;
Tamés, María José;
Cajaraville, Gerardo

Publication type:

Article

Evaluating genomic biomarkers associated with resistance or sensitivity to chemotherapy in patients with advanced breast and colorectal cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1371, doi. 10.1177/1078155220951845

By:

Guenter, Jolene;
Abadi, Shirin;
Lim, Howard;
Chia, Stephen;
Woods, Ryan;
Jones, Martin;
Rebic, Nevena;
Renouf, Daniel J;
Laskin, Janessa;
Marra, Marco

Publication type:

Article

Is the duration of castration resistance predictive for sequential treatment responses in the metastatic castration-resistant prostate cancer setting?

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1388, doi. 10.1177/1078155220951612

By:

Dülgar, Özgecan;
Özyükseler, Deniz Tataroğlu;
Başak, Mustafa;
Ay, Seval;
Tural, Deniz;
Yıldırım, Mahmut Emre;
Gümüş, Mahmut

Publication type:

Article

Long term stability of an admixture of alizapride and ondansetron in 0.9% sodium chloride solution polyolefin bags stored at 5±3°C.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1328, doi. 10.1177/1078155220950442

By:

Closset, Mélanie;
Goderniaux, Nicolas;
Colsoul, Marie-Lise;
Soumoy, Laura;
Bihin, Benoit;
Jamart, Jacques;
Odou, Pascal;
Hecq, Jean-Daniel;
Galanti, Laurence

Publication type:

Article

Permeation measurement of 27 chemotherapy drugs after simulated dynamic testing on 15 surgical and examination gloves: A knowledge update.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1395, doi. 10.1177/1078155220950423

By:

Nalin, Marie;
Hug, Guillaume;
Boeckmans, Eric;
Machon, Christelle;
Favier, Bertrand;
Guitton, Jérôme

Publication type:

Article